Can radiation risks to patients be reduced without reducing radiation exposure? The status of chemical radioprotectants

American Journal of Roentgenology

Volumn 196, Issue 3, 2011, Pages 616-618

  Mettler Jr , Fred A ^a   Brenner, David ^b   Coleman, C Norman ^c   Kaminski, Joseph M ^d   Kennedy, Ann R ^e   Wagner, Louis K ^f  

^a Department of Radiology and Nuclear Medicine Service   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Chemical radioprotectants; Radiation risk

Indexed keywords

ACETYLCYSTEINE; ALPHA TOCOPHEROL; ALPHA TOCOPHEROL DERIVATIVE; ALPHA TOCOPHEROL SUCCINATE; AMIFOSTINE; ASCORBIC ACID; CURCUMIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLAVONOID; GINKGO BILOBA EXTRACT; NITROXIDE; POLYPHENOL; PROCYANIDIN; PROSTAGLANDIN; REACTIVE OXYGEN METABOLITE; RESVERATROL; SELENIUM; SELENOMETHIONINE; SUPEROXIDE DISMUTASE; THIOCTIC ACID; TRACE ELEMENT; UBIDECARENONE;

ANAPHYLAXIS; ANTIOXIDANT ACTIVITY; CARCINOGENESIS; CHROMOSOME DAMAGE; DIAGNOSTIC PROCEDURE; GINKGO BILOBA; HAIR LOSS; HUMAN; HYPERTENSION; IMMUNE FUNCTION TEST; INTERVENTIONAL RADIOLOGY; NAUSEA; NONHUMAN; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIATION HAZARD; RADIATION PROTECTION; REVIEW; SKIN MANIFESTATION; VITAMIN SUPPLEMENTATION; VOMITING;

AMIFOSTINE; DIAGNOSTIC IMAGING; HUMANS; RADIATION PROTECTION; RADIATION-PROTECTIVE AGENTS; RISK; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 79952260299     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.10.4959     Document Type: Review

References (20)

1. Mettler FA Jr, Bhargavan M, Faulkner K, et al. Radiologic and nuclear medicine studies in the United States and worldwide: frequency, radiation dose, and comparison with other sources - 1950-2007. Radiology 2009; 253:521-531
2. World Health Organization (WHO). Ionizing radiation. Part 1. X and gamma radiation and neutrons, vol. 75, IARC monographs on the evaluation of carcinogenic risks to humans. Lyon, France: International Agency for Research on Cancer, 2000
3. International Commission on Radiological Protection. Managing patient dose in computed tomography - ICRP Publication 87. Ann ICRP 2000;30:[web]
4. Brenner DJ, Elliston CD. Estimated radiation risks potentially associated with full-body CT screening. Radiology 2004; 232:735-738 (Pubitemid 39100257)
5. Brenner DJ. Estimating cancer risks from pediatric CT: going from the qualitative to the quantitative. Pediatr Radiol 2002; 32:228-231 (Pubitemid 36075689)
6. Berrington de Gonzalez A, Mahesh M, Kim KP, et al. Projected cancer risks from CT scans performed in the US in 2007. Arch Intern Med 2009;169:2071-2077
7. Kuehn BM. FDA warning: CT scans exceeded proper doses. JAMA 2010; 303:124
8. Koenig TR, Mettler FA, Wagner LK. Skin injuries from fluoroscopically guided procedures. Part 2. Review of 73 cases and recommendations for minimizing dose delivered to the patient. AJR 2001;177:13-20 (Pubitemid 32578044)
9. National Research Council. Health risks from exposures to low-levels of ionizing radiation, BEIR VII Report, Phase 2. Washington, D.C.: National Academies Press, 2006:157-170
10. Dumont F, Le Roux A, Bischoff P. Radiation countermeasure agents: an update. Expert Opin Ther Pat 2010; 20:73-101
11. Weiss JF, Landauer MR. History and development of radiation-protective agents. Int J Radiat Biol 2009; 85:539-573
12. Hall E, Giaccia A. Radiobiology for the radiologist, 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2006
13. Coleman CN, Blakely WF, Fike JR, et al. Molecular and cellular biology of moderate-dose (1-10 Gy) radiation and potential mechanisms of radiation protection: report of a workshop at Bethesda, Maryland, December 17-18, 2001. Radiat Res 2003; 159:812-834 (Pubitemid 36676875)
14. Grdina DJ, Murley JS, Kataoka Y, Epperly W. Relationships between cytoprotection and mutation prevention by WR-1065. Mil Med 2002; 167[2 suppl]:51-53 (Pubitemid 34174183)
15. Kumar KS, Srinivasin V, Toles R, Jobe L, Seed TM. Nutritional approaches to radioprotection: vitamin E. Mil Med 2002; 167[2 suppl]:57-59 (Pubitemid 34174185)
16. Kennedy AR. Factors that modify radiation-induced carcinogenesis. Health Phys 2009; 97:433-445
17. Chen CS, Wells PG. Enhanced tumorigenesis in p-53 knockout mice exposed in-utero to high dose vitamin E. Carcinogenesis 2006; 27:1358-1368 (Pubitemid 43985411)
18. Miller ER 3rd, Guallar E. Vitamin E supplementation: what's the harm in that? Clin Trials 2009;6:47-49
19. Miller ER 3rd, Pastor-Barriuso R, Dalal D. Metaanalysis: high-dose vitamin E supplementation may increase all-cause mortality. Ann Intern Med 2005; 142:37-46
20. Fletcher RH, Fairfield KM. Vitamins for chronic disease prevention in adults: clinical applications. JAMA 2002; 287:3127-3129 (Pubitemid 34633988)